Co-Delivery of Docetaxel and Curcumin via Nanomicelles for Enhancing Anti-Ovarian Cancer Treatment

INTRODUCTIONS: Ovarian cancer is a stubborn malignancy of gynecological system with a high mortality rate. Docetaxel (DTX), the second-generation of anti-tumor drug Taxane, has shown superior efficacy over classic paclitaxel (PTX) in certain cancers. However, its clinical application is hindered by...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Yuzhu, Ran, Mengni, Wang, Bilan, Lin, Yunzhu, Cheng, Yongzhong, Zheng, Songping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7721301/
https://www.ncbi.nlm.nih.gov/pubmed/33299312
http://dx.doi.org/10.2147/IJN.S274083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7721301/
https://www.ncbi.nlm.nih.gov/pubmed/33299312
http://dx.doi.org/10.2147/IJN.S274083

Ejemplares similares